Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Chinese Patent Office
Farmers Insurance
Argus Health
Daiichi Sankyo
Teva
Fuji
Covington
AstraZeneca

Generated: November 21, 2018

DrugPatentWatch Database Preview

SILENOR Drug Profile

« Back to Dashboard

Which patents cover Silenor, and when can generic versions of Silenor launch?

Silenor is a drug marketed by Pernix Theraps Llc and is included in one NDA. There are nine patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in SILENOR is doxepin hydrochloride. There are seven drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the doxepin hydrochloride profile page.

Drug patent expirations by year for SILENOR
Pharmacology for SILENOR
Medical Subject Heading (MeSH) Categories for SILENOR
Synonyms for SILENOR
(3-(6H-dibenzo[c,f]oxepin-11-ylidene)propyl)dimethylamine, chloride
(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethyl-1-propanamine hydrochloride
(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethyl-propan-1-amine hydrochloride
(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine hydrochloride
(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine;hydrochloride
(3Z)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine hydrochloride
(e)-doxepin hydrochloride
(Z)-Doxepin hydrochloride
(Z)-N,N-Dimethyldibenz(b,e)oxepin-delta(sup 11(6H),gamma)-propylamine hydrochloride
1-Propanamine, 3-dibenz(b,e)oxepin-11-(6H)-ylidene-N,N-dimethyl-dimethyl-, hydrochloride, (E)-
1-Propanamine, 3-dibenz(b,e)oxepin-11(6H)-ylidene-N,N-dimethyl-, hydrochloride, (Z)-
1-Propanamine, 3-dibenz(b,e)oxepin-11(6H)ylidene-N,N-dimethyl-, hydrochloride
1-Propanamine, 3-dibez[b,e]oxepin-11(6H)-ylidene-N,N-dimethyl-, hydrochloride
1-Propanamine,e]oxepin-11(6H)-ylidene-N,N-dimethyl-, hydrochloride
1-Propanamine,e]oxepin-11(6H)ylidene-N,N-dimethyl-, hydrochloride
11-(3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin hydrochloride
11-(3-Dimethylaminopropylidene)-6,11-dihydro-benz[b,e]Oxepin
11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin hydrochloride
11-(3-Dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepine hydrochloride
11-(3-Dimethylaminopropylidene)-6,11-dihydrodibenzo[b,e]oxepine Hydrochloride
11-(Dimethylamino)propylidene 6H-dibenz[b,e]oxepin
11-dimethylaminopropylidene6h-dibenz(b,e)oxepin
11[16h]-[3-(dimethylamino)-propylidene]dibenz[b,e]oxepine hydrochloride
1229-29-4
20917-44-6
229D294
25127-31-5
25197-84-6
3-Dibenz(b,c)oxepin 11(6H)ylidene-N,N-dimethyl-1-propanamine
3-dibenz(b,c)oxepin 11(6h)ylidene-n,n-dimethyl-1-propanamine hydrochloride
4698-39-9
A804993
AB0109368
AC-8076
AC1NQY0E
AC1O4WGB
Adapin
AKOS015895087
AKOS024458484
API0002487
Aponal
AS-13316
BG0175
C-19460
C19H21NO.HCl
CAS-1229-29-4
CCG-220263
CCG-221643
CCG-38932
CHEBI:4711
CHEMBL1200462
CHEMBL1256774
Cidoxepin HCl
Cidoxepin hydrochloride
Cidoxepin hydrochloride (USAN)
Cidoxepin hydrochloride [USAN]
cis-Doxepin hydrochloride
CPD000058230
CPD000449270
CS-2972
CU61C5RH24
Curatin
D 4526
D00814
D03491
D4626
Dibenz(b,e)oxepin-delta(sup 11(6H),gamma)-propylamine, N,N-dimethyl-, hydrochloride
Dibenz(b,e)oxepin-delta11(6H),gamma-propylamine, N,N-dimethyl-, hydrochloride
Dibenz(b,e)oxepin-delta11(6H),gamma-propylamine, N,N-dimethyl-, hydrochloride (8CI)
Dibenz[b,.gamma.-propylamine, N,N-dimethyl-, hydrochloride
Dibenz[b,.gamma.)-propylamine, N,N-dimethyl-, hydrochloride
dimethyl(3-{9-oxatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene}propyl)amine hydrochloride
Doxepin (Hydrochloride)
Doxepin (Z)-isomer hydrochloride
Doxepin cis-form hydrochloride
Doxepin for system suitability, European Pharmacopoeia (EP) Reference Standard
Doxepin HCl
Doxepin hydrochlorid
Doxepin Hydrochloride
Doxepin hydrochloride (E)-isomer
Doxepin hydrochloride (USP)
Doxepin hydrochloride [USAN:USP]
Doxepin Hydrochloride [USAN]
Doxepin Hydrochloride 1.0 mg/ml in Methanol (as free base)
Doxepin hydrochloride, ~85% E-isomer basis, >=98% (GC), 15% Z-isomer basis, powder
Doxepin hydrochloride, European Pharmacopoeia (EP) Reference Standard
Doxepin hydrochloride, United States Pharmacopeia (USP) Reference Standard
Doxepine hydrochloride
DSSTox_CID_25145
DSSTox_GSID_45145
DSSTox_RID_80701
DTXSID8045145
EINECS 214-966-8
EU-0100339
H882
HMS1568F08
HMS1920I22
HY-B0725
I06-0502
J10288
Jsp001539
KS-5094
LP00339
LS-61639
MF 10 HCl
MFCD00079135
MLS000069794
MLS000758259
MLS001148235
MLS001423974
MLS002207250
MLS002222181
MLS002548858
MolPort-003-666-170
MolPort-003-872-120
N,e]oxepin-.delta. (sup11(6H),.gamma.)-propylamine hydrochloride
N,e]oxepin-.delta.-11(6H).gamma.-propylamine HCl
N,e]oxepin-.DELTA.11(6H),.gamma.-propylamine hydrochloride
N,e]oxepin-.DELTA.11(6H),.gamma.-propylamine, hydrochloride
N,N-Dimethyldibenz(b,e)oxepin-delta(sup 11(6H),gamma)-propylamine hydrochloride
NC00052
NC00447
NCGC00015344-03
NCGC00024623-04
NCGC00093778-01
NCGC00093778-02
NCGC00094661-01
NCGC00094661-02
NCGC00261024-01
Novoxapin
Novoxapin hydrochloride
NSC-108160
NSC-756750
NSC108160
NSC756750
Opera_ID_675
P 4599
P-3693A
P-4599
Pharmakon1600-01500264
Prestwick_187
Q-201044
SAM001246976
SAM002264608
SBB005916
SC-62324
SCHEMBL124597
SCHEMBL60287
Sinequan
Sinequin
SMR000058230
SMR000449270
SPECTRUM1500264
SR-01000075551
SR-01000075551-1
ST025239
timtec-bb sbb005916
Toruan
Tox21_110130
Tox21_110130_1
Tox21_500339
trans-Doxepin hydrochloride
UNII-3U9A0FE9N5 component MHNSPTUQQIYJOT-CULRIWENSA-N
UNII-3U9A0FE9N5 component MHNSPTUQQIYJOT-SJDTYFKWSA-N
UNII-CU61C5RH24
UNII-XI27WMG8QK
WLN: T C676 IO&T&J B3N1&1 &GH
XI27WMG8QK
Zonalon
Zonalon (TN)

US Patents and Regulatory Information for SILENOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pernix Theraps Llc SILENOR doxepin hydrochloride TABLET;ORAL 022036-001 Mar 17, 2010 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pernix Theraps Llc SILENOR doxepin hydrochloride TABLET;ORAL 022036-002 Mar 17, 2010 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Pernix Theraps Llc SILENOR doxepin hydrochloride TABLET;ORAL 022036-001 Mar 17, 2010 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pernix Theraps Llc SILENOR doxepin hydrochloride TABLET;ORAL 022036-001 Mar 17, 2010 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pernix Theraps Llc SILENOR doxepin hydrochloride TABLET;ORAL 022036-002 Mar 17, 2010 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pernix Theraps Llc SILENOR doxepin hydrochloride TABLET;ORAL 022036-001 Mar 17, 2010 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Pernix Theraps Llc SILENOR doxepin hydrochloride TABLET;ORAL 022036-002 Mar 17, 2010 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for SILENOR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pernix Theraps Llc SILENOR doxepin hydrochloride TABLET;ORAL 022036-002 Mar 17, 2010 ➤ Try a Free Trial ➤ Try a Free Trial
Pernix Theraps Llc SILENOR doxepin hydrochloride TABLET;ORAL 022036-002 Mar 17, 2010 ➤ Try a Free Trial ➤ Try a Free Trial
Pernix Theraps Llc SILENOR doxepin hydrochloride TABLET;ORAL 022036-001 Mar 17, 2010 ➤ Try a Free Trial ➤ Try a Free Trial
Pernix Theraps Llc SILENOR doxepin hydrochloride TABLET;ORAL 022036-001 Mar 17, 2010 ➤ Try a Free Trial ➤ Try a Free Trial
Pernix Theraps Llc SILENOR doxepin hydrochloride TABLET;ORAL 022036-001 Mar 17, 2010 ➤ Try a Free Trial ➤ Try a Free Trial
Pernix Theraps Llc SILENOR doxepin hydrochloride TABLET;ORAL 022036-001 Mar 17, 2010 ➤ Try a Free Trial ➤ Try a Free Trial
Pernix Theraps Llc SILENOR doxepin hydrochloride TABLET;ORAL 022036-002 Mar 17, 2010 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for SILENOR
Drugname Dosage Strength RLD Date
➤ Subscribe Tablets 3 mg and 6 mg ➤ Subscribe ➤ Try a Free Trial

International Patents for SILENOR

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Chinese Patent Office
Farmers Insurance
Argus Health
Daiichi Sankyo
Teva
Fuji
Covington
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.